- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
FluroTech Ltd. Announces CompleTest(TM) Commercialization
![Cannabis Investing](https://investingnews.com/media-library/cannabis-investing.png?id=27869511&width=1200&height=800&quality=80&coordinates=61%2C0%2C62%2C0)
FluroTech (TSXV:TEST), (“FluroTech” or the “Company”) is pleased to announce that it has finalized the engineering & design of its flagship product, CompleTest™, and engaged a third party manufacturer to produce the first commercial production run of the housing for the CompleTest™ Series 1 device.
FluroTech (TSXV:TEST), (“FluroTech” or the “Company”) is pleased to announce that it has finalized the engineering & design of its flagship product, CompleTest™, and engaged a third party manufacturer to produce the first commercial production run of the housing for the CompleTest™ Series 1 device.
The desktop device will commence commercial production July 2018 and is expected to be available for sale in Canada by October 2018, along with the first of a series of test kits that will be made available sequentially to the Cannabis industry over the next year and a half. Sales to international markets are expected in the first half of 2019.
“Over a decade of research has gone into the development of the CompleTest™ devices and test kits,” stated Dr. Elmar Prenner, Chief Technology Officer. “We believe this disruptive technology is a step change when compared to conventional high-performance liquid chromatography and mass spectroscopy, which require trained lab technicians to perform experiments and interpret complex sets of data.” Dr. Prenner explained that because the CompleTest™ allows users to obtain highly accurate results within minutes rather than waiting days or weeks for results from third party labs, it may allow cannabis producing companies to move from a compliance mindset to optimizing production by providing them tools to produce the highest quality products for their consumers.
Cross lab variability and a desire to understand one’s product before sending it for third party certification has led Canadian licensed producers and international growers to express a keen interest to be able to carry out in-house quality control and THC/CBD potency optimization.
“Opportunities for effective cannabis testing technology continue to expand with the recent legalization of recreational cannabis in Canada,” explained Danny Dalla-Longa, Chief Executive Officer. “CompleTest™ will fill a gap in the testing market, enabling growers, retailers and regulators to employ a user friendly, in-house option to affordably test cannabis, resulting in fast, accurate and repeatable results.”
About CompleTest™
CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of- the-art cannabis testing device, able to provide quick, accurate and consistent testing results. It’s designed for cultivators, dispensaries and anyone with a vested interest in consumer safety to test the quality and safety of their cannabis products and to optimize potency yield.
About FluroTech (TSXV: TEST)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.
To learn more, visit www.FluroTech.com and watch our video.
Contact Information
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com
Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com
Prit Singh
IR — Thesis Capital Inc.
905.510.7636
psingh@thesiscapital.ca
Click here to connect with FluroTech (TSXV:TEST) for an Investor Presentation.
Source: www.newsfilecorp.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.